Solving the puzzle for a deadly problem
April 6, 2021
UC researchers are opening a national clinical trial to see if a therapy that has shown promise in treating lung and uterine cancer could be applied to pancreatic cancer, too.
April 6, 2021
UC researchers are opening a national clinical trial to see if a therapy that has shown promise in treating lung and uterine cancer could be applied to pancreatic cancer, too.
July 21, 2020
National media outlets report on new UC findings that show immunotherapy will not worsen complications for patients who have cancer and COVID-19.
September 22, 2020
Drugs.com covers UC research looking at mortality in patients with cancer and COVID-19.
September 22, 2020
WVXU reports on a University of Cincinnati study showing cancer patients undergoing a combination of chemotherapy and immunotherapy one to three months before a COVID-19 diagnosis have a greater risk of death than patients who haven't undergone cancer treatment in the past year.
September 1, 2020
Brett Kissela, MD, senior associate dean for clinical research at the UC College of Medicine, served as an example for the research he oversees and conducts, as he became a participant in the Moderna vaccine trial.
September 19, 2020
University of Cincinnati researchers have found that certain treatments for cancer may increase the chance of death if they contract COVID-19.
August 6, 2020
During a pandemic, cancer is all the more terrifying, uncertain, and lonely. UC Cancer Center researchers weigh in.
August 15, 2022
Drs Melanie Cushion, Michael Farrell and Bruce Giffin have been named 2022 recipients of Daniel Drake Medals.
April 22, 2021
Taejeong Song, PhD, a postdoctoral fellow in the UC College of Medicine, says a regulatory protein found in skeletal muscle fiber may play an important role in the body’s fight or flight response when encountering dangerous situations.
May 13, 2021
Donald Lynch Jr., MD, assistant professor at the University of Cincinnati College of Medicine, will be presenting preliminary research at the American College of Cardiology on Saturday, May 15, that suggests plasma proteins discovered in the blood samples of diabetic patients who went on to develop obstructive coronary disease (OCAD) may serve as biomarkers of severe heart blockage.